FDA approves first anti-TFPI antibody for haemophilia A and B

被引：0
|
作者：
Mullard, Asher
机构：
来源：
NATURE REVIEWS DRUG DISCOVERY | 2024年 / 23卷 / 12期
关键词：
D O I：
10.1038/d41573-024-00175-4
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
引用
收藏
页码：884 / 884
页数：1
相关论文
共 50 条
  • [1] FDA approves first haemophilia B gene therapy
    Mullard, Asher
    NATURE REVIEWS DRUG DISCOVERY, 2023, 22 (01) : 7 - 7
  • [2] FDA approves first haemophilia B gene therapy
    Asher Mullard
    Nature Reviews Drug Discovery, 2023, 22 : 7 - 7
  • [3] In Vitro and In Vivo Characterization of Marstacimab, an Anti-TFPI Antibody
    Parng, Chuenlei
    Jin, Macy
    Holsti, Matthew
    Benard, Susan
    Rakhe, Swapnil
    Patel-Hett, Sunita R.
    Joyce, Alison
    Webster, Rob
    Pittman, Debra D.
    BLOOD, 2019, 134
  • [4] Improvement in thrombin generation by the anti-TFPI antibody, concizumab, in plasma from individuals with haemophilia a with or without inhibitors or haemophilia B, is not affected by the presence of corn trypsin inhibitor
    Waters, E. K.
    Hilden, I
    Dhillon, S.
    Rea, C. J.
    Sorensen, B. B.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 671 - 671
  • [5] FDA approves first monoclonal antibody for COPD
    Mullard, Asher
    NATURE REVIEWS DRUG DISCOVERY, 2024, 23 (11) : 805 - 805
  • [6] FDA approves first monoclonal antibody for radioimmunotherapy
    不详
    BIOTECHNOLOGY LAW REPORT, 2002, 21 (04) : 337 - 338
  • [7] FDA approves first biparatopic antibody therapy
    Mullard, Asher
    NATURE REVIEWS DRUG DISCOVERY, 2025, 24 (01) : 7 - 7
  • [8] Concizumab: a novel anti-TFPI therapeutic for hemophilia
    Shapiro, Amy D.
    BLOOD ADVANCES, 2021, 5 (01) : 279 - 279
  • [9] FDA approves first anti-ANGPTL3 antibody, for rare cardiovascular indication
    Mullard, Asher
    NATURE REVIEWS DRUG DISCOVERY, 2021, 20 (04) : 251 - 251
  • [10] Safety and pharmacokinetics of anti-TFPI antibody (concizumab) in healthy volunteers and patients with hemophilia: a randomized first human dose trial
    Chowdary, P.
    Lethagen, S.
    Friedrich, U.
    Brand, B.
    Hay, C.
    Karim, F. Abdul
    Klamroth, R.
    Knoebl, P.
    Laffan, M.
    Mahlangu, J.
    Miesbach, W.
    Nielsen, J. Dalsgaard
    Martin-Salces, M.
    Angchaisuksiri, P.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 (05) : 743 - 754
12345